NPI registry status
Active
2026 NPPES data Neurology Physician NPI 1821054230 MD
Verify on CMS → Noah Gilson, MD
Neurology Physician in West Long Branch, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 20,467 in Neurology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 442 beneficiaries · Neurology Physician avg: 1K
Generic prescribing
81%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$66.51
4 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Noah Gilson, MD carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 2,645 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 3K
- Part D claims, 2024
- 81%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Noah Gilson, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1821054230), first enumerated 04/25/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,645 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$66.51 in reported industry payments (4 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1821054230 · Neurology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1821054230
- ENUM-LEGACY 2006
- TAX-MID 20K Neurology Physician
- MIPS-NEUTRAL 75/100
- RX-MID 2,645
- BOOK-LIGHT 535 in New Jersey
- PHOTO-ENUM Bahram Nico, M.D. · 2006
Noah Gilson, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
2,645 ≥ 87th percentile 87% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Noah Gilson, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Noah Gilson, MD?
CMS neutral score, not measuredPrimary specialty
Neurology Physician
Medicare Part D claims
2,645 95% vs specialty avg
MIPS final score
75/100
Specialty distribution in New Jersey
How Neurology Physician compares to other specialties among New Jersey providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1821054230 |
|---|---|
| Specialty | Neurology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/25/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Noah Gilson, MD. Source: openpaymentsdata.cms.gov.
Total received
$67
Largest payer
PFIZER INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Noah Gilson, MD - brand share 18.0%
Neurology Physician average
18% brand-name claims vs 81% generic, on 2,645 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,645
Total Claims
$2.0M
Total Drug Cost
442
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,956.367
- Total Day Supply
- 144,918
- Brand vs Generic
- 18% brand / 81% generic
- Brand Drug Cost
- $1.9M
- Generic Drug Cost
- $98K
- Opioid Claims
- 37 (1.4% rate)
Patient Demographics
- Average Patient Age
- 75.1 years
- Avg HCC Risk Score
- 1.45
- Gender Split
- 54% female / 46% male
- Age Distribution
- <65: 44, 65-74: 140, 75-84: 178, 85+: 80
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Noah Gilson, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Donepezil Hcl
Donepezil Hcl
256 claims
- Carbidopa-Levodopa
Carbidopa-Levodopa
183 claims
- Levetiracetam
Levetiracetam
140 claims
- Gabapentin
Gabapentin
121 claims
- Memantine Hcl
Memantine Hcl
120 claims
- Lamotrigine 94
Lamotrigine
94 claims
- Rytary 75
Rytary
75 claims
- Clonazepam 69
Clonazepam
69 claims
| Drug | Claims |
|---|---|
| Donepezil Hcl | 256 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 183 |
| Levetiracetam | 140 |
| Gabapentin | 121 |
| Memantine Hcl | 120 |
| Lamotrigine | 94 |
| Rytary Carbidopa/Levodopa | 75 |
| Clonazepam | 69 |
| Escitalopram Oxalate | 52 |
| Pyridostigmine Bromide | 52 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neurology Physician Overview
How Noah Gilson, MD fits within the Neurology Physician landscape nationally.
20,467
Neurology Physician Providers in US
54
States with Neurology Physician
1,356
Avg Claims per Provider
Noah Gilson, MD's 2,645 claims are above the specialty average of 1,356.
Nationwide Neurology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Gilson, both outside New Jersey so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Neurology Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Gilson.
One of 535 Neurology Physician providers enrolled in New Jersey, 5 are shown here.
Dr. S Abidi
MD
Maple Shade, NJ
Dr. Russell Abrams
M.D.
Cherry Hill, NJ
Dr. Osama Abu-Hadid
M.D.
Paramus, NJ
Dr. Shashank Agarwal
M.D
Livingston, NJ
Dr. Antwan Ahad
MD
Secaucus, NJ
Compare Neurology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Noah Gilson, MD's specialty? ▼
Noah Gilson, MD specializes in Neurology Physician and practices in West Long Branch, New Jersey. Credentials: MD.
How much does Noah Gilson, MD prescribe under Medicare Part D? ▼
In 2024, Noah Gilson, MD wrote 2,645 Medicare Part D claims totaling $2.0M in drug costs for 442 beneficiaries.
What is Noah Gilson, MD's Medicare quality score? ▼
Noah Gilson, MD has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Noah Gilson, MD located? ▼
Noah Gilson, MD is located at 107 MONMOUTH RD, West Long Branch, NJ, 07764. Phone: (732) 935-1850.
What is Noah Gilson, MD's NPI number? ▼
Noah Gilson, MD's National Provider Identifier (NPI) is 1821054230, issued on 04/25/2006.
Does Noah Gilson, MD prescribe more brand-name or generic drugs? ▼
Noah Gilson, MD's prescribing is 18% brand-name and 81% generic drugs by claim count, with $1.9M in brand drug costs.
Does Noah Gilson, MD prescribe opioids? ▼
Yes, Noah Gilson, MD had 37 opioid claims in 2024 with an opioid prescribing rate of 1.4%.
How many Neurology Physician providers are there in the US? ▼
There are 20,467 Neurology Physician providers across 54 states in the US. The average Neurology Physician provider writes 1,356 Medicare Part D claims per year.
What drugs does Noah Gilson, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Noah Gilson, MD's most frequently prescribed drugs include Donepezil Hcl, Carbidopa-Levodopa, Levetiracetam. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Noah Gilson, MD accept Medicare? ▼
Noah Gilson, MD appears in CMS Medicare data with 2,645 Part D claims and 442 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Noah Gilson, MD's credentials? ▼
Noah Gilson, MD's NPI is 1821054230 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.